Author: Evelyn Lee
Expert Series: What is the Borderline? Case Studies (Part 2)
.media-object__meta > li:nth-child(2){ display:none; } .media-object__meta > li:nth-child(1){ display:none; } .media-object__meta > li:nth-child(3){ margin-left:0px; } .author-card{ display:none; } .block__sidebar, .pagination{…
Expert Series: What is the Borderline? (Part 1)
.media-object__meta > li:nth-child(2){ display:none; } .media-object__meta > li:nth-child(1){ display:none; } .media-object__meta > li:nth-child(3){ margin-left:0px; } .author-card{ display:none; } .block__sidebar, .pagination{…
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell Response and COVID Vaccination in Ethnic Minority Groups
.media-object__meta > li:nth-child(2){ display:none; } .author-card{ display:none; } .block__sidebar, .pagination{ display:none; } .masthead__content-wrapper{ display:none !important; } .media-object__meta{ display:none !important; }…
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in UK Com-COV Clinical Trial to Investigate the T Cell Response in Different Combinations of Approved COVID-19 Vaccines for the First and Second Doses
.media-object__meta > li:nth-child(2){ display:none; } .author-card{ display:none; } .block__sidebar, .pagination{ display:none; } .masthead__content-wrapper{ display:none !important; } .media-object__meta{ display:none !important; }…
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection
.media-object__meta > li:nth-child(2){ display:none; } .author-card{ display:none; } .block__sidebar, .pagination{ display:none; } .masthead__content-wrapper{ display:none !important; } .media-object__meta{ display:none !important; }…